53 completed, 11 unknown, 5 not yet recruiting, 4 withdrawn. 77 Phase 1, 15 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 77 | Completed 53, Unknown 11, Not yet recruiting 5, Withdrawn 4, Recruiting 3, Terminated 1 |
| Phase 2 | 15 | Unknown 6, Completed 5, Recruiting 2, Withdrawn 2 |
Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline Viaca, Sildenafil 50 mg, Cabergoline 0.5 MG - Erectile Dysfunctions, Healthy Volunteer | Phase 1 | Not yet recruiting | Yanping Kong | 30 | 2026-08-01 | 2026-07-28 |
| Stem Cells for Erectile Dysfunction Post RALP Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office, Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR, Placebo in the OR - Erectile Dysfunction, Prostate Cancer | Phase 1 / Phase 2 | Recruiting | The Methodist Hospital Research Institute | 40 | 2026-07-07 | 2026-07-10 |
| Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject ASP-001.1, ASP-001, Commercial Sildenafil and Sildenafil/Tadalafil Products - Erectile Dysfunction | Phase 1 | Not yet recruiting | Aspargo Labs, Inc | 72 | 2026-01-01 | 2025-12-12 |
| A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers Tadalafil 10 MG - Erectile Dysfunction | Phase 1 | Unknown | Seattle Gummy Company | 30 | 2025-05-01 | 2024-06-13 |
| Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil uc-msc secretome intra cavernous injection - Erectile Dysfunctions | Phase 1 | Not yet recruiting | Universitas Indonesia | 10 | 2025-04-21 | 2025-02-25 |
| The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects ASP-001.1 - Erectile Dysfunction | Phase 1 | Recruiting | Aspargo Labs, Inc | 12 | 2025-04-15 | 2025-11-19 |
| Evaluating the Efficacy of Platelet-Rich-Plasma (PRP) for Erectile Dysfunction Platelet-Rich-Plasma, Saline - Erectile Dysfunction | Phase 1 | Unknown | University of Manitoba | 60 | 2025-01-24 | 2025-01-28 |
| Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants. ASP-001, Viagra - Erectile Dysfunction | Phase 1 | Not yet recruiting | Aspargo Labs, Inc | 56 | 2025-01-01 | 2025-01-20 |
| Erectile Dysfunction Treatment Using Stem Cells UC-MSCs and PRP - Erectile Dysfunction | Phase 1 / Phase 2 | Unknown | COR clinic of Regenerative Medicine | 30 | 2024-08-10 | 2024-08-13 |
| A Phase 1 Trial of LIB-01 in Healthy Participants. LIB-01, Placebo - Erectile Dysfunction | Phase 1 | Completed | Dicot AB | 64 | 2023-08-25 | 2024-05-30 |
| Radiological Evaluation of the Penis Before and After a Botox Injection Injection of Botulinum neurotoxin (BoNT), Penile duplex and shear wave elastosonography (SWE). - Erectile Dysfunction | Phase 1 / Phase 2 | Unknown | Cairo University | 32 | 2023-06-01 | 2023-09-21 |
| DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction DualStim Therapy, Umbilical cord-derived Wharton's Jelly, Saline - Erectile Dysfunction | Phase 1 / Phase 2 | Unknown | BioIntegrate | 60 | 2023-01-01 | 2022-07-21 |
| A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol Tunodafil Hydrochloride Tablets, Placebo, Alcohol - Erectile Dysfunction | Phase 1 | Completed | Yangtze River Pharmaceutical Group Co., Ltd. | 22 | 2022-12-19 | 2023-08-04 |
| Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered BZ371A - Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction | Phase 1 | Completed | Biozeus Biopharmaceutical S.A. | 12 | 2022-11-16 | 2025-03-07 |
| Effect of TPN171H on Spermatogenesis TPN171H 10mg, TPN171H Placebo - Erectile Dysfunction | Phase 1 | Completed | Vigonvita Life Sciences | 18 | 2022-11-15 | 2023-02-21 |
| Stem Cell Treatment of Peyronie´s Disease. Stromal vascular fraction - Penile Induration, Penile Diseases | Phase 1 | Completed | Esbjerg Hospital - University Hospital of Southern Denmark | 22 | 2022-09-09 | 2024-07-31 |
| Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction Shock Wave therapy (SWT), Platelet Rich Plasma (PRP), Sham SWT - Erectile Dysfunction | Phase 1 | Completed | University of Miami | 59 | 2022-06-27 | 2026-05-22 |
| A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects TPN171H single dose - Pulmonary Arterial Hypertension, Erectile Dysfunction | Phase 1 | Completed | Vigonvita Life Sciences | 16 | 2022-03-31 | 2024-12-24 |
| PRP for the Treatment of Erectile Dysfunction (ED) Autologous Platelet Rich Plasma - Erectile Dysfunction | Phase 1 | Completed | Mayo Clinic | 4 | 2022-03-04 | 2023-10-27 |
| A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects TPN171H tablet plus alcohol, alcohol, TPN171H tablet - Alcohol, Phosphodiesterase Inhibitor | Phase 1 | Completed | Vigonvita Life Sciences | 19 | 2022-02-24 | 2022-05-23 |
Showing 20 of 77. Sign in to see all of them.
Prostatic Hyperplasia (4) · Cardiovascular Diseases (3) · Diabetes Mellitus, Type 1 (3) · Prostatic Neoplasms (3) · Sexual Dysfunction, Physiological (3) · Alzheimer Disease (2) · Autoimmune Diseases (2) · Cardiomyopathies (2) · Diabetes Mellitus, Type 2 (2) · Heart Diseases (2) · Lung Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Penile Induration (2)
Genital Diseases (77) · Genital Diseases, Male (77) · Male Urogenital Diseases (77) · Sexual Dysfunctions, Psychological (77) · Urogenital Diseases (77) · Mental Disorders (76) · Sexual Dysfunction, Physiological (74) · Prostatic Diseases (7) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Endocrine System Diseases (5) · Diabetes Mellitus (4) · Glucose Metabolism Disorders (4) · Immune System Diseases (4) · Metabolic Diseases (4)
Sildenafil Citrate (13) · avanafil (7) · Ethanol (4) · 2-(5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)-2-n-propoxyphenyl)-5-ethyl-7-n-propyl-3,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one dihydrochloride (3) · Tadalafil (3) · udenafil (3) · Extracorporeal Shockwave Therapy (2) · Lipectomy (2) · Nitroglycerin (2) · Sodium Chloride (2) · Tamsulosin (2) · Vardenafil Dihydrochloride (2) · 1-(6-ethoxy-5-(3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo(4,3-d)pyrimidin-5-yl)-3-pyridyl sulphonyl)-4-ethylpiperazine (1) · Administration, Sublingual (1) · Ambulatory Care Facilities (1)
VIVUS LLC (9) · Vigonvita Life Sciences (6) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (5) · Hanmi Pharmaceutical Company Limited (4) · Aspargo Labs, Inc (3) · SK Chemicals Co., Ltd. (3) · Bayer (2) · Chinese Academy of Sciences (2) · Ageless Regenerative Institute (1) · Ain Shams University (1) · Asan Medical Center (1) · Assaf-Harofeh Medical Center (1) · Baylor College of Medicine (1) · BioIntegrate (1) · Biozeus Biopharmaceutical S.A. (1)
United States (22) · China (11) · South Korea (7) · Israel (3) · Singapore (3) · Brazil (2) · Canada (2) · Egypt (2) · United Kingdom (2) · Antigua and Barbuda (1) · Australia (1) · Denmark (1) · France (1) · Germany (1) · Jordan (1)
Shiyin Yee, PhD (5) · Gangyi Liu (2) · In-Jin Jang, MD (2) · Minsu Park, M.D., Ph.D. (2) · Abdallah Awidi, MD (1) · Andrey A Pulin, MD, PhD (1) · Arthur L Burnett, M.D., M.B.A. (1) · Ashim Gupta, PhD, MBA (1) · Chadwick Prodromos, MD (1) · Chen Yu (1) · Chuck Bowden, M.D. (1)
PMID 25974235, PMID 24447534, PMID 26439886, PMID 26745574, PMID 28753830, PMID 34326007, PMID 36280578, PMID 38965462, PMID 40181588, PMID 40255110, PMID 40277393
2009 (1), R01DK130991 (1)